News
Mexican patent office grants patent protection for Vigorous Solutions fast-acting sildenafil solutions
Chinese National Intellectual Property Administration grants patent protection for Vigorous Solutions novel fast-acting sildenafil solutions
Eurasian patent protection for Vigorous Solutions sildenafil solutions is granted in Russia, Turkmenistan, Belarus, Tajikistan, Azerbaijan, Kazakhstan, Kyrgyzstan, and Armenia
Israel Patent Authority issues notice of allowance for Vigorous Solutions novel sildenafil solution products
Second pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation as the fastest absorbed and highest bioavailable Sildenafil product
Vigorous Solutions receives a second U.S. patent allowance, issued to expand the protection of its proprietary liquid sildenafil formulations
Vigorous Solutions is issued its first U.S. patent allowance, covering an expansive variety of liquid solutions
European patent registers Vigorous Solutions product in all 38 European countries
Grant Patent issued to Vigorous Solutions by the European Patent Office
First pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation’s superiority in time-to-absorption vs Pfizer’s Viagra®.
Vigorous Solutions receives a patent allowance in South Africa encompassing a variety of its liquid solutions
Vigorous Solutions successfully secures $3 Million in seed funding from private investors